KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Exact Sciences (EXAS) over the last 14 years, with Q3 2025 value amounting to -$626000.0.

  • Exact Sciences' Change in Accured Expenses fell 15332.2% to -$626000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.0 million, marking a year-over-year decrease of 18037.6%. This contributed to the annual value of $9.7 million for FY2024, which is 5357.65% up from last year.
  • As of Q3 2025, Exact Sciences' Change in Accured Expenses stood at -$626000.0, which was down 15332.2% from -$7.2 million recorded in Q2 2025.
  • Exact Sciences' Change in Accured Expenses' 5-year high stood at $12.8 million during Q2 2024, with a 5-year trough of -$7.2 million in Q2 2025.
  • Its 4-year average for Change in Accured Expenses is $71733.3, with a median of -$1.2 million in 2023.
  • Data for Exact Sciences' Change in Accured Expenses shows a peak YoY increase of 475086.21% (in 2023) and a maximum YoY decrease of 33888.45% (in 2023) over the last 5 years.
  • Over the past 4 years, Exact Sciences' Change in Accured Expenses (Quarter) stood at $1.3 million in 2022, then skyrocketed by 502.77% to $7.6 million in 2023, then tumbled by 118.26% to -$1.4 million in 2024, then soared by 54.93% to -$626000.0 in 2025.
  • Its last three reported values are -$626000.0 in Q3 2025, -$7.2 million for Q2 2025, and -$5.8 million during Q1 2025.